Schenck M&A Solutions advises Gammex on the sale to Sun Nuclear

7/22/2014

NEWS RELEASE

For Immediate Release
July 22, 2014

Contact: 
Ann Hanna, MBA, CPA
Managing Director, Schenck M&A Solutions
ann.hanna@schencksc.com

Schenck M&A Solutions announced Sun Nuclear Corporation of Melbourne, Florida will acquire Gammex, Inc. of Middleton, Wisconsin effective July 2, 2014. Schenck advised Gammex, Inc. throughout this transaction. The acquisition combines two complementary product lines within the radiation oncology marketplace, and adds diagnostic radiology Quality Assurance (QA) capability to Sun Nuclear’s already dominant therapeutic radiation oncology QA and dosimetry position. 

“I am excited to see these two companies combine because of their deep synergies” said Margaret Lescrenier, President of Gammex Inc. “We started Gammex in 1969 and have been pioneers in radiation oncology and diagnostic products for over 40 years. We see a promising future for continued innovation and growth of the Gammex product line under the new leadership of Sun Nuclear.”

“We are very excited to bring Gammex into the Sun Nuclear family,” says Jeff Simon, CEO of Sun Nuclear. “Gammex has a long history of meaningful innovation and technical expertise that fits perfectly with Sun Nuclear’s core values and mission. We believe Gammex is a company of great opportunity, and look forward to providing the market leadership in quality assurance and patient safety that Sun Nuclear is known for today, and to continue Gammex’s rich history of innovation. We are also excited to make this investment in Middleton (Madison), Wisconsin, a recognized world leader in the Medical Physics and cancer care industry, and home to the University of Wisconsin.”

About Gammex, Inc.

Gammex is a pioneer in radiation oncology and diagnostic products since its founding in 1969 by Charles and Margaret Lescrenier. Gammex’s pioneering product development is contained in three fundamental technology movements. First, Gammex provided the first patented commercial laser alignment solution, establishing a standard of precision patient alignment now employed by every radiotherapy treatment facility throughout the world. Second, Gammex offered the world’s first commercial water equivalent material, SolidWater®, which has also become a worldwide standard for Medical Physicists. Third, Gammex pioneered innovations in diagnostic imaging phantom technology, with breakthrough products for Mammography, Ultrasound, and CT, and which remain the gold standard to this day.

About Schenck M&A Solutions

Schenck M&A Solutions, a division of Schenck SC, consists of a dedicated group of investment banking professionals providing M&A advisory services for business sales and divestitures, acquisitions, management buyouts and recapitalizations. The M&A team approaches transactions with creativity, a strong sense of urgency and the negotiation skills and deal expertise critical to complete transactions in the best interests of their clients. Schenck M&A Solutions is uniquely positioned having the dedicated M&A experience of a boutique investment bank backed by the breadth of knowledge and resources of a large accounting and advisory firm.


SECURITIES OFFERED THROUGH BURCH & COMPANY, INC., MEMBER FINRA & SIPC. BURCH & COMPANY AND SCHENCK M&A SOLUTIONS ARE NOT AFFILIATED ENTITIES. ANN HANNA AND COREY VANDERPOEL OF SCHENCK M&A SOLUTIONS ARE REGISTERED INVESTMENT BANKING REPRESENTATIVES WITH BURCH & COMPANY.

###